GLP-1 receptor agonists can manage postprandial glucose
(HealthDay)—Glucagon-like peptide 1 (GLP-1) receptor agonists appear beneficial for postprandial glucose management in type 2 diabetes, according to a report published in the October issue of Clinical Diabetes.
Nov 17, 2015
0
7